GSA Capital Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-10,016
Closed -$92K – 2023
2024
Q3
$92K Buy
+10,016
New +$82.9K 0.01% 1497
2024
Q2
– Sell
-87,510
Closed -$1.32M – 2021
2024
Q1
$1.32M Buy
87,510
+37,424
+75% +$679K 0.1% 275
2023
Q4
$1.08M Sell
50,086
-11,739
-19% -$217K 0.09% 352
2023
Q3
$1.15M Buy
+61,825
New +$1.44M 0.1% 331
2023
Q2
– Sell
-13,744
Closed -$356K – 1937
2023
Q1
$356K Buy
+13,744
New +$368K 0.04% 921
2022
Q4
– Sell
-22,586
Closed -$573K – 1875
2022
Q3
$573K Buy
22,586
+6,043
+37% +$212K 0.08% 473
2022
Q2
$549K Buy
16,543
+10,764
+186% +$457K 0.08% 438
2022
Q1
$417K Buy
+5,779
New +$416K 0.06% 663
2021
Q3
– Sell
-1,209
Closed -$201K – 1760
2021
Q2
$201K Buy
+1,209
New +$196K 0.02% 1184
2020
Q2
– Sell
-1,599
Closed -$248K – 1089
2020
Q1
$248K Buy
+1,599
New +$186K 0.06% 613

Other funds holding TDOC

GSA Capital Partners's TDOC Position: Q4 2024 in Review

GSA Capital Partners sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 10,016 shares — an estimated $92K sold.

GSA Capital Partners first reported a position in TDOC in Q1 2020 and held it in 10 quarters. The position peaked at $1.32M in Q1 2024. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • GSA Capital Partners reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 10,016 Teladoc Health shares in Q4 2024, an estimated $92K.
  • GSA Capital Partners first reported a position in Teladoc Health in Q1 2020 and held it in 10 quarters.
  • GSA Capital Partners's Teladoc Health position peaked at $1.32M in Q1 2024.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.